NCT00001317View on ClinicalTrials.gov

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 1992

Study Completion Date

July 31, 2001

Conditions
Chronic Granulomatous Disease
Interventions
DRUG

interferon-gamma

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH